Skip to main content
Clinical Trials/NCT02416869
NCT02416869
Completed
Phase 4

Effectiveness of Different Application Modalities of Dexamethasone on Clinical Parameters and Quality of Life After Lower Third Molar Surgery

University of Belgrade1 site in 1 country60 target enrollmentJanuary 2014

Overview

Phase
Phase 4
Intervention
Intramuscular application
Conditions
Impacted Third Molar Tooth
Sponsor
University of Belgrade
Enrollment
60
Locations
1
Primary Endpoint
Facial swelling (using 3 facial measurements (in millimeters)
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

The aim of this randomized double-blind cross over clinical trial is to investigate effectiveness of different routes of applications (intramuscular and submucous at the site of surgery) and doses (4 mg and 8 mg) of Dexamethasone on swelling, trismus, pain and quality of life after lower third molar surgery.

Registry
clinicaltrials.gov
Start Date
January 2014
End Date
April 2019
Last Updated
7 years ago
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Miroslav Andric

Assistant Professor

University of Belgrade

Eligibility Criteria

Inclusion Criteria

  • Healthy patients (ASA I)
  • Bilateral symmetrically impacted lower third molars according to Pel-Gregory's and Winter's classification

Exclusion Criteria

  • Heavy tobacco smokers
  • Drug and / or alcohol abusers

Arms & Interventions

Intramuscular application

Intramuscular application of 4mg Dexamethasone

Intervention: Intramuscular application

Submucosal application

Submucosal application of 4mg Dexamethasone

Intervention: Submucosal application

4mg Dexamethasone submucosal

4mg Dexamethasone submucosal application

Intervention: 4mg Dexamethasone submucosal

8mg Dexamethasone submucosal

8mg Dexamethasone submucosal application

Intervention: 8mg Dexamethasone submucosal

4mg Dexamethasone postoperative

4mg Dexamethasone postoperative application

Intervention: 4mg Dexamethasone preoperative

4mg Dexamethasone preoperative

4mg Dexamethasone postoperative application

Intervention: 4mg Dexamethasone postoperative

Outcomes

Primary Outcomes

Facial swelling (using 3 facial measurements (in millimeters)

Time Frame: 1 day, 3 day, 7 day

We followed facial swelling 1, 3 and 7 days after intervention. Swelling in the operation site will be evaluated using 3 facial measurements (in millimeters): 1. Tragus - Midline. 2. Tragus - Corner of the mouth 3. Gonion - Lateral canthus.

Secondary Outcomes

  • Postoperative pain (visual analog scale)(1 day, 3 day, 7 day)
  • Postoperative trismus (difference in interincisal distance at the maximal mouth opening (in millimeters) before and after surgery)(1 day, 3 day, 7 day)
  • Postoperative discomfort (25-items custom made questionnaire)(4 day, 7 day)

Study Sites (1)

Loading locations...

Similar Trials